136 related articles for article (PubMed ID: 18030045)
1. Bilateral ovarian metastases from breast carcinoma on FDG PET-CT.
Ho L; Quan V; Henderson R
Clin Nucl Med; 2007 Dec; 32(12):935-6. PubMed ID: 18030045
[TBL] [Abstract][Full Text] [Related]
2. Bilateral ovarian metastases from gastric carcinoma on FDG PET/CT.
Ho L; Wassef H; Nakla A; Henderson R
Clin Nucl Med; 2012 May; 37(5):524-7. PubMed ID: 22475913
[TBL] [Abstract][Full Text] [Related]
3. Unilateral ovarian metastasis from gastric mucinous adenocarcinoma visualized on FDG PET/CT.
Tamam MO; Mulazimoglu M; Kamali G; Eker O; Ozpacaci T
Eur Rev Med Pharmacol Sci; 2012 Oct; 16 Suppl 4():1-3. PubMed ID: 23090794
[TBL] [Abstract][Full Text] [Related]
4. Solitary breast metastasis from recurrent gallbladder carcinoma simulating a second primary on 18F-FDG PET/CT.
Khangembam BC; Sharma P; Naswa N; Sahoo MK; Kumar R
Clin Nucl Med; 2013 Nov; 38(11):e433-4. PubMed ID: 24096996
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: a case report and literature review.
Susini T; Olivieri S; Molino C; Castiglione F; Tavella K; Viligiardi R
J Womens Health (Larchmt); 2010 Jan; 19(1):169-74. PubMed ID: 20088673
[TBL] [Abstract][Full Text] [Related]
6. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
8. Ileal Neuroendocrine Tumor With Bilateral Breast and Ovarian Metastases: Findings on 68Ga-DOTANOC PET/CT Scan.
Tripathy S; Naswa N; Jha P; Reddy S; Parida GK
Clin Nucl Med; 2019 Sep; 44(9):e532-e534. PubMed ID: 31274557
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effect of 89Sr for multiple bone metastases of breast cancer: diagnosis by 18F-FDG PET/CT.
Hama Y
Clin Nucl Med; 2014 Apr; 39(4):e290-1. PubMed ID: 23917785
[TBL] [Abstract][Full Text] [Related]
11. Ovarian metastases: computed tomographic appearances.
Megibow AJ; Hulnick DH; Bosniak MA; Balthazar EJ
Radiology; 1985 Jul; 156(1):161-4. PubMed ID: 4001405
[TBL] [Abstract][Full Text] [Related]
12. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of sequential FDG-PET/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers.
Katayama T; Kubota K; Machida Y; Toriihara A; Shibuya H
Ann Nucl Med; 2012 Jun; 26(5):426-35. PubMed ID: 22477261
[TBL] [Abstract][Full Text] [Related]
14. Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma.
Chin K; Finger PT; Kurli M; Tena LB; Reddy S
Optometry; 2007 Aug; 78(8):396-401. PubMed ID: 17662928
[TBL] [Abstract][Full Text] [Related]
15. Discordant findings of skeletal metastasis between tc 99M MDP bone scans and F18 FDG PET/CT imaging for advanced breast and lung cancers--two case reports and literature review.
Chen YW; Huang MY; Hsieh JS; Hou MF; Chou SH; Lin CL
Kaohsiung J Med Sci; 2007 Dec; 23(12):639-46. PubMed ID: 18192101
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
[TBL] [Abstract][Full Text] [Related]
17. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
[TBL] [Abstract][Full Text] [Related]
18. Value of 18fluoro-deoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.
Bender H; Kirst J; Palmedo H; Schomburg A; Wagner U; Ruhlmann J; Biersack HJ
Anticancer Res; 1997; 17(3B):1687-92. PubMed ID: 9179219
[TBL] [Abstract][Full Text] [Related]
19. [Ovarian metastasis of extragenital tumors at the Zurich University Gynecologic Clinic 1978-1990].
Perucchini D; Caduff R; Schär G; Fink D; Köchli OR
Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):351-6. PubMed ID: 8964449
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Cancer and Breast Metastases: A Diagnostic Dilemma.
Kridis WB; Sghaier S; Charfi S; Toumi N; Chaabène K; Boudawara T; Khanfir A
Arch Iran Med; 2020 Jan; 23(1):53-55. PubMed ID: 31910635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
